HLIB Research said Optimax’s strategic exposure to upcoming thematic plays in 2026 and 2027 could provide upside earnings surprises.
PETALING JAYA: Hong Leong Investment Bank (HLIB) Research has initiated coverage on Optimax Holdings Bhd
with a “buy” recommendation and a target price of 96 sen a share, valuing the counter at 30 times fully diluted financial year ending Dec 31, 2026 (FY26) earnings.
HLIB Research said the valuation reflected Optimax’s strong positioning in Malaysia’s fast-growing medical eye care industry and its transition into the “asset-milking” stage “characterised by margin recovery through economies of scale and progressive deleveraging”.
